SSA/Ps are believed to become serrated pathway cancers via a series of molecular alternations, including BRAF mutation and CpG island methylation, with epigenetic inactivation of the mismatch repair gene MLH1 resulting in microsatellite instability [5]. The gene discussed is MLH1; the disease is cancer.